๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

CD8+ T cells in atopic disease

โœ Scribed by David M Kemeny


Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
600 KB
Volume
10
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

โœฆ Synopsis


In recent years there has been a tremendous expansion in our understanding about CD8(+) T cells. We now know that, as for CD4(+) T cells, they can be divided into subsets (Tc1 and Tc2) according to the cytokines they secrete. These subsets may differ in their capacity to kill and may even, in some cases, provide help for B cell antibody production or be involved in the induction of inflammatory responses. In addition, there is a host of cross-regulatory networks between different CD4(+) and CD8(+) subsets that control the magnitude and duration of immune responses. The observation that some antigens that are normally presented by MHC class II and seen by CD4(+) T cells can be presented by MHC class I and stimulate CD8(+) T cells increases the possibility for such interactions. During the next few years we can expect that our understanding of the biology of CD8(+) T cells and their role in immunity will increase.


๐Ÿ“œ SIMILAR VOLUMES


CD8+ T cells in autoimmunity
โœ Ulrich Walter; Pere Santamaria ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 157 KB

Mounting evidence shows that CD8 + T cells contribute to the initiation, progression and regulation of several pathogenic autoimmune responses in which these cells were not previously thought to play a major role. CD8 + T cells can kill target cells directly, by recognizing peptide-MHC complexes on

CD38 expression on cryopreserved CD8+ T
โœ Stephen P. Perfetto; John D. Malone; Clifton Hawkes; Gilbert McCrary; Bob August ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 140 KB

Previous studies have revealed that the expression of CD38 on CD8 ฯฉ T cells is a strong predictor of disease progression in human immunodeficiency virus (HIV)-infected individuals. Those studies were performed using fresh patient samples over an extended trial period. After demonstrating the validit

CD8+T cells in systemic sclerosis
โœ Patrizia Fuschiotti ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 341 KB
Pathogenic CD8+ T cells in multiple scle
โœ Manuel A. Friese; Lars Fugger ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 243 KB ๐Ÿ‘ 2 views